Growth of an Affimer-antibody mixed immunological prognosis equipment for glypican-3. Glypican-3 (GPC3) is a promising new marker for hepatocellular carcinoma, however the reported values for serum GPC3 differ markedly between at the moment accessible kits. Right here we remoted Affimer non-antibody binding proteins…
